PanGIA’s test approach pairs proprietary chemistry with machine learning to detect cancer-specific biosignatures from urine ...

Personalis, Inc. , a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study showing for the first time its ultrasensitive NeXT ...

A blood sample analysis can detect markers of this disease at early stages, providing a cheaper and less invasive option for diagnosis. In clinical trials, the Lumipulse blood test was highly ...

In the UK, more than 400,000 people are told they have cancer every year. Statistics suggest that nearly one in two of us ...

Guardant Health, Inc. (NASDAQ:GH) and research collaborators have unveiled results from the largest study to date on ...

PanGIA Biotech, a leader in non-invasive cancer diagnostics, presented findings at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) from a prospective, multi-center ...

THE six deadliest cancers in the UK have been identified in a new report – accounting for 67,000 deaths every year. The ...

Personalized whole-genome sequencing (WGS) panels utilizing up to 1,000 somatic variants were successfully created via Precise MRD for 97.3% of patients tested. Precise MRD detected tumor fractions as ...

Gary and other Lake County residents are being asked to help gauge dangerous pollutants after an initial study found ...

One important blood test report will come tomorrow which we are ... to be done we hope and pray they don’t have any signs of cancer. He urged fans to pray for Dipika's health like they did ...

To do that, researchers used a blood test to find mutations in cancer cells that let the tumors defy standard treatments. Early detection allowed patients to be switched to a different drug that ...

The early switch approach in women with hormone receptor-positive, HER2-negative breast cancer resulted in a 56% reduction in ...